Lucio Iannone ^Investor

Lucio Iannone is an experienced Head of Health Venture Investments at Leaps by Bayer, with a strong background in biotechnology and a passion for advancing innovative therapies. He serves on multiple boards, driving groundbreaking research in cancer therapeutics and gene editing technologies. Lucio's expertise in venture investments and strategic decision-making has led to successful collaborations with top healthcare innovators. His achievements include publications in prestigious journals and recognition for his contributions to pulmonary hypertension research. With a commitment to science and a focus on creating impactful solutions, Lucio is dedicated to improving patient outcomes through cutting-edge medical advancements.